Skip to content
AnalystLens
Back to EXELCash Flow

Exelixis Free Cash Flow 2009-2027 | EXEL

Annual FY2009–FY2026 · quarterly through Q3 FY2027

Latest annual · FY2026

$875.8M

+30.4%YoY vs FY2025Source: 10-KFY2026

From −$20.5M in FY2009 to $875.8M in FY2026.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY27$250M+20.1%$301M+552.0%$277M−3.9%Not reported
FY26$208M+252.6%$46M−59.1%$289M+9.8%$332M+40.7%
FY25$59M$113M$263M$236M
FY23$72M−49.1%$115M+383.5%$108M+2.8%$22M−41.9%
FY22$142M+446.9%$24M−85.2%$105M+52.6%$38M−79.8%
Share22%20%28%30%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date. Share: its typical part of the fiscal year.

Key Statistics

Trend DirectionGrowing
CAGR

+11.2%

FY2020
$514.1M
FY2026
$875.8M

5 years selected · on the chart

Free Cash Flow History

Year-over-year comparison from 10-K annual reports

  1. $875.8M
YoY changeLargest recent move+164.7%in FY18Latest +30.4%

3 older moves run past ±150% (largest −401.8%); point at, tap or drag across the bars to read one.

Free Cash Flow, period by period

PeriodValueChangeSource
FY2026$875.8M+30.4%10-K
FY2025$671.5M+129.3%10-K
FY2023$292.9M−12.6%10-K
FY2022$334.9M−3.4%10-K
FY2021$346.6M−32.6%10-K
FY2020$514.1M+34.4%10-K
FY2018$382.4M+164.7%10-K
FY2017$144.5M−30.8%10-K
FY2016$208.7M+246.9%10-K
FY2015−$142.0M+39.8%10-K
FY2014−$235.9M−17.4%10-K
FY2013−$200.9M−59.7%10-K
FY2012−$125.9M+21.4%10-K
FY2011−$160.2M−55.8%10-K
FY2010−$102.9M−401.8%10-K
FY2009−$20.5M—10-K

What is Exelixis's current free cash flow?

Exelixis (EXEL) annual free cash flow for 2026 was $875.8M, a 30.42% increase from 2025. Exelixis free cash flow for the quarter ending October 2, 2026 was $277.5M.

What was Exelixis's free cash flow in 2025?

Exelixis annual free cash flow for 2025 was $671.5M, a 129.31% increase from 2023.

What was Exelixis's free cash flow in 2023?

Exelixis annual free cash flow for 2023 was $292.9M, a 12.56% decline from 2022.

What is Exelixis's 5-year free cash flow CAGR?

Exelixis free cash flow grew at a compound annual growth rate (CAGR) of 20.37% from FY2021 to FY2026, going from $346.6M to $875.8M over 5 years.

Company
Exelixis
Ticker
EXEL
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)